capitalbio dna microarray (CapitalBio Corporation)
Structured Review
Capitalbio Dna Microarray, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capitalbio+dna+microarray/capitalbio++dna+microarray/pm38850839-299-11-11
Average 90 stars, based on 1 article reviews
Images
Related Articles
Microarray:Article Title: Rapid and accurate detection of rifampin and isoniazid-resistant Mycobacterium tuberculosis using an oligonucleotide array. Article Snippet: Distribution of gene mutations among 179 multidrug-resistantMycobacterium tuberculosis isolates detected by the array Gene and mutation No. (%) of isolatesarpoB katG inhA-r S531L S315T1 30 (16.8) S531L C-15T 21 (11.7) S531L S315N 11 (6.1) S531L T-8C 9 (5.0) D516V S315T1 8 (4.5) S531L S315T1 C-15T 6 (3.4) H526Y S315T1 5 (2.8) L533P S315T1 5 (2.8) aOut of 84 (46.9%) isolates, fewer than five strains harboured the same profiles of mutation. a2013 The Authors Clinical Microbiology and Infection a2013 European Society of Clinical Microbiology and Infectious Diseases, CMI a2013 The Authors Clinical Microbiology and Infection a2013 European Society of Clinical Microbiology and Infectious Diseases, CMI study was better able to detect rifampin resistance (p <0.01) and isoniazid resistance (p <0.05) compared with the CapitalBio DNA microarray. .. In our study, H526N was found in 3.6% (9/247) of the rifampin-resistant isolates, and the corresponding probe was not included in the Article Title: Diagnostic performance of DNA microarray for detecting rifampicin and isoniazid resistance in Mycobacterium tuberculosis Article Snippet: .. Zhang et al. ( 28 ) assessed the performance of the Article Title: Diagnostic performance of DNA microarray for detecting rifampicin and isoniazid resistance in Mycobacterium tuberculosis Article Snippet: .. Recently, Zhang et al. ( 22 ) tested 2,143 sputum specimens from previously treated patients in Changchun, China, for RFP and INH resistance-related gene mutations by using the BACT/MGIT 960 culture system and the Article Title: Exploring diagnostic methods for drug-resistant tuberculosis: A comprehensive overview. Article Snippet: Despite available global efforts and funding, Tuberculosis (TB) continues to affect a considerable number of patients worldwide.. Policy makers and stakeholders set clear goals to reduce TB incidence and mortality, but the emergence of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) complicate the reach of these goals.. Drug-resistance TB needs to be diagnosed rapidly and accurately to effectively treat patients, prevent the transmission of MDR-TB, minimise mortality, reduce treatment costs and avoid unnecessary hospitalisations. |

